Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Randomization	STARTED	Luspatercept	182
Randomization	STARTED	Epoetin Alfa	181
Randomization	COMPLETED	Luspatercept	182
Randomization	COMPLETED	Epoetin Alfa	179
Randomization	NOT COMPLETED	Luspatercept	0
Randomization	NOT COMPLETED	Epoetin Alfa	2
Treatment	STARTED	Luspatercept	182
Treatment	STARTED	Epoetin Alfa	179
Treatment	COMPLETED	Luspatercept	78
Treatment	COMPLETED	Epoetin Alfa	53
Treatment	NOT COMPLETED	Luspatercept	104
Treatment	NOT COMPLETED	Epoetin Alfa	126

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03682536/flow